title: Boronated monoclonal antibodies for potential neutron capture therapy of malignant melanoma and leukaemia.
authors.affiliation: Department of Pharmacy, University of Sydney, Australia.
authors.forename: S R
authors.initials: SR
authors.lastname: Tamat
authors.forename: A
authors.initials: A
authors.lastname: Patwardhan
authors.forename: D E
authors.initials: DE
authors.lastname: Moore
authors.forename: A
authors.initials: A
authors.lastname: Kabral
authors.forename: K
authors.initials: K
authors.lastname: Bradstock
authors.forename: P
authors.initials: P
authors.lastname: Hersey
authors.forename: B J
authors.initials: BJ
authors.lastname: Allen
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology*; D001896:Boron Compounds / Q000276:immunology*; D004337:Drug Carriers; D006801:Humans; D007554:Isotopes; D007942:Leukemia, Experimental / Q000532:radiotherapy*; D008546:Melanoma, Experimental / Q000532:radiotherapy*; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D009502:Neutrons; D011882:Radiotherapy, High-Energy / Q000379:methods*
chemical_list: D000911:Antibodies, Monoclonal; D001896:Boron Compounds; D004337:Drug Carriers; D007554:Isotopes